Eligibility Pre-Screening

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 70%

1.Have you been diagnosed with hepatocellular carcinoma (liver cancer, HCC)?

Press Y/N or 1/2